APPLICATION OF MIRTAZAPINE IN CHRONIC PAIN SYNDROME

APPLICATION OF MIRTAZAPINE IN CHRONIC PAIN SYNDROME Arslonova Rayhon Razhabboyevna Samarkand State Medical University, Department of Pharmacology, Assistant Uzoqova Mehribon Akmal kizi Samarkand State Medical University Treatment faculty 2of course Ergashov Saddam Rakhmatovich Samarkand State Medical University Treatment faculty 3of course https://doi.org/10.5281/zenodo.15133094 Конец формы Abstract: Chronic pain syndrome is a disease characterized by persistent, poorly treatable pain syndrome lasting more than 6 months. Such pain syndrome in most cases is the result of somatic disease or trauma. The main cause of chronic pain syndrome is long-term persistent pain, which causes an imbalance in the peripheral and central nervous system. Neuronal receptors and fibers in this case are subjected to constant activation, which leads to increased stimulation of the central nervous system (spinal cord and brain) by pain stimuli. One of the main causes of chronic pain is the appearance of complexes of hyperreactive neurons at various levels of the CNS. Their pathologic activity is caused by the breakdown of neuronal inhibition mechanisms, increased excitability of neurons and activation of inactive synapses, which unites these neurons into a single focus of excitation with self-sustained ectopic activity. This activity leads to functional, structural, and adaptive (neuroplastic) changes in the brain and spinal cord, causing pain to persist even when its cause is eliminated. There are many medications currently used to treat chronic pain, one of which is the widely used mirtazapine. Keywords: Chronic pain syndrome, Mirtazapine, Neuronal receptors, antidepressant, sedative and hypnotic drugs.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-04-03
DOI
https://doi.org/10.5281/zenodo.15133094
Primary Topic
Pain Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

APPLICATION OF MIRTAZAPINE IN CHRONIC PAIN SYNDROME

Zenodo (CERN European Organization for Nuclear Research)
Pain Mechanisms and Treatments
article

APPLICATION OF MIRTAZAPINE IN CHRONIC PAIN SYNDROME

article en

Abstract

APPLICATION OF MIRTAZAPINE IN CHRONIC PAIN SYNDROME Arslonova Rayhon Razhabboyevna Samarkand State Medical University, Department of Pharmacology, Assistant Uzoqova Mehribon Akmal kizi Samarkand State Medical University Treatment faculty 2of course Ergashov Saddam Rakhmatovich Samarkand State Medical University Treatment faculty 3of course https://doi.org/10.5281/zenodo.15133094 Конец формы Abstract: Chronic pain syndrome is a disease characterized by persistent, poorly treatable pain syndrome lasting more than 6 months. Such pain syndrome in most cases is the result of somatic disease or trauma. The main cause of chronic pain syndrome is long-term persistent pain, which causes an imbalance in the peripheral and central nervous system. Neuronal receptors and fibers in this case are subjected to constant activation, which leads to increased stimulation of the central nervous system (spinal cord and brain) by pain stimuli. One of the main causes of chronic pain is the appearance of complexes of hyperreactive neurons at various levels of the CNS. Their pathologic activity is caused by the breakdown of neuronal inhibition mechanisms, increased excitability of neurons and activation of inactive synapses, which unites these neurons into a single focus of excitation with self-sustained ectopic activity. This activity leads to functional, structural, and adaptive (neuroplastic) changes in the brain and spinal cord, causing pain to persist even when its cause is eliminated. There are many medications currently used to treat chronic pain, one of which is the widely used mirtazapine. Keywords: Chronic pain syndrome, Mirtazapine, Neuronal receptors, antidepressant, sedative and hypnotic drugs.

Zenodo (CERN European Organization for Nuclear Research)
Samarkand State Medical Institute (UZ)
Openalex Percentile: Top 44%
Pain Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.